These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 33946151)

  • 21. Apatinib affect VEGF-mediated cell proliferation, migration, invasion via blocking VEGFR2/RAF/MEK/ERK and PI3K/AKT pathways in cholangiocarcinoma cell.
    Huang M; Huang B; Li G; Zeng S
    BMC Gastroenterol; 2018 Nov; 18(1):169. PubMed ID: 30400838
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of topoisomerase IIα and induction of DNA damage in cholangiocarcinoma cells by altholactone and its halogenated benzoate derivatives.
    Kitdumrongthum S; Reabroi S; Suksen K; Tuchinda P; Munyoo B; Mahalapbutr P; Rungrotmongkol T; Ounjai P; Chairoungdua A
    Biomed Pharmacother; 2020 Jul; 127():110149. PubMed ID: 32344256
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antitumor Effect of Shikonin, a PKM2 Inhibitor, in Cholangiocarcinoma Cell Lines.
    Thonsri U; Seubwai W; Waraasawapati S; Wongkham S; Boonmars T; Cha'on U; Wongkham C
    Anticancer Res; 2020 Sep; 40(9):5115-5124. PubMed ID: 32878800
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Terminal fucose mediates progression of human cholangiocarcinoma through EGF/EGFR activation and the Akt/Erk signaling pathway.
    Indramanee S; Sawanyawisuth K; Silsirivanit A; Dana P; Phoomak C; Kariya R; Klinhom-On N; Sorin S; Wongkham C; Okada S; Wongkham S
    Sci Rep; 2019 Nov; 9(1):17266. PubMed ID: 31754244
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mycoepoxydiene induces apoptosis and inhibits TPA-induced invasion in human cholangiocarcinoma cells via blocking NF-κB pathway.
    Li W; Li M; Su X; Qin L; Miao M; Yu C; Shen Y; Luo Q; Chen Q
    Biochimie; 2014 Jun; 101():183-91. PubMed ID: 24486723
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High glucose upregulates FOXM1 expression via EGFR/STAT3 dependent activation to promote progression of cholangiocarcinoma.
    Detarya M; Thaenkaew S; Seubwai W; Indramanee S; Phoomak C; Saengboonmee C; Wongkham S; Wongkham C
    Life Sci; 2021 Apr; 271():119114. PubMed ID: 33513399
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeted Modulation of FAK/PI3K/PDK1/AKT and FAK/p53 Pathways by Cucurbitacin B for the Antiproliferation Effect Against Human Cholangiocarcinoma Cells.
    Klungsaeng S; Kukongviriyapan V; Prawan A; Kongpetch S; Senggunprai L
    Am J Chin Med; 2020; 48(6):1475-1489. PubMed ID: 32907364
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epidermal growth factor receptor (EGFR) antibody down-regulates mutant receptors and inhibits tumors expressing EGFR mutations.
    Perez-Torres M; Guix M; Gonzalez A; Arteaga CL
    J Biol Chem; 2006 Dec; 281(52):40183-92. PubMed ID: 17082181
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TRAIL Enhances Shikonin Induced Apoptosis through ROS/JNK Signaling in Cholangiocarcinoma Cells.
    Zhou G; Yang Z; Wang X; Tao R; Zhou Y
    Cell Physiol Biochem; 2017; 42(3):1073-1086. PubMed ID: 28662515
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SP1-induced HOXD-AS1 promotes malignant progression of cholangiocarcinoma by regulating miR-520c-3p/MYCN.
    Li J; Jiang X; Li Z; Huang L; Ji D; Yu L; Zhou Y; Cui Y
    Aging (Albany NY); 2020 Aug; 12(16):16304-16325. PubMed ID: 32857725
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quinoline-based clioquinol and nitroxoline exhibit anticancer activity inducing FoxM1 inhibition in cholangiocarcinoma cells.
    Chan-On W; Huyen NT; Songtawee N; Suwanjang W; Prachayasittikul S; Prachayasittikul V
    Drug Des Devel Ther; 2015; 9():2033-47. PubMed ID: 25897210
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SVCT-2 determines the sensitivity to ascorbate-induced cell death in cholangiocarcinoma cell lines and patient derived xenografts.
    Wang C; Lv H; Yang W; Li T; Fang T; Lv G; Han Q; Dong L; Jiang T; Jiang B; Yang G; Wang H
    Cancer Lett; 2017 Jul; 398():1-11. PubMed ID: 28385602
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diethyldithiocarbamate suppresses an NF-kappaB dependent metastatic pathway in cholangiocarcinoma cells.
    Srikoon P; Kariya R; Kudo E; Goto H; Vaeteewoottacharn K; Taura M; Wongkham S; Okada S
    Asian Pac J Cancer Prev; 2013; 14(7):4441-6. PubMed ID: 23992017
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Artesunate and chloroquine induce cytotoxic activity on cholangiocarcinoma cells via different cell death mechanisms.
    Guragain D; Seubwai W; Kobayashi D; Silsinivanit A; Vaeteewoottacharn K; Sawanyawisuth K; Wongkham C; Wongkham S; Araki N; Cha'on U
    Cell Mol Biol (Noisy-le-grand); 2018 Jul; 64(10):113-118. PubMed ID: 30084802
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Matuzumab and cetuximab activate the epidermal growth factor receptor but fail to trigger downstream signaling by Akt or Erk.
    Yoshida T; Okamoto I; Okabe T; Iwasa T; Satoh T; Nishio K; Fukuoka M; Nakagawa K
    Int J Cancer; 2008 Apr; 122(7):1530-8. PubMed ID: 18033688
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The IGF2/IR/IGF1R Pathway in Tumor Cells and Myofibroblasts Mediates Resistance to EGFR Inhibition in Cholangiocarcinoma.
    Vaquero J; Lobe C; Tahraoui S; Clapéron A; Mergey M; Merabtene F; Wendum D; Coulouarn C; Housset C; Desbois-Mouthon C; Praz F; Fouassier L
    Clin Cancer Res; 2018 Sep; 24(17):4282-4296. PubMed ID: 29716918
    [No Abstract]   [Full Text] [Related]  

  • 37. Nimotuzumab Inhibits Cholangiocarcinoma Cell Metastasis
    Padthaisong S; Thanee M; Techasen A; Namwat N; Yongvanit P; Liwatthakun A; Hankla K; Sangkhamanon S; Loilome W
    Anticancer Res; 2017 Jul; 37(7):3591-3597. PubMed ID: 28668850
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combined targeting of AKT and mTOR using MK-2206 and RAD001 is synergistic in the treatment of cholangiocarcinoma.
    Ewald F; Grabinski N; Grottke A; Windhorst S; Nörz D; Carstensen L; Staufer K; Hofmann BT; Diehl F; David K; Schumacher U; Nashan B; Jücker M
    Int J Cancer; 2013 Nov; 133(9):2065-76. PubMed ID: 23588885
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Depolymerized Fractions of Sulfated Galactans Extracted from
    Kamble MT; Rudtanatip T; Soowannayan C; Nambunruang B; Medhe SV; Wongprasert K
    Mar Drugs; 2022 Jul; 20(8):. PubMed ID: 35892937
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increase of MAL-II Binding Alpha2,3-Sialylated Glycan Is Associated with 5-FU Resistance and Short Survival of Cholangiocarcinoma Patients.
    Wattanavises S; Silsirivanit A; Sawanyawisuth K; Cha'on U; Waraasawapati S; Saentaweesuk W; Luang S; Chalermwat C; Wongkham C; Wongkham S
    Medicina (Kaunas); 2019 Nov; 55(12):. PubMed ID: 31795149
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.